Hicks M E, Surratt R S, Picus D, Marx M V, Lang E V
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
AJR Am J Roentgenol. 1990 Apr;154(4):725-8. doi: 10.2214/ajr.154.4.2107665.
We reviewed our experience with 158 consecutive patients who underwent either percutaneous gastrostomy or percutaneous gastroenterostomy during a 2-year period. The catheters used included Foley catheters (36), Cope-type gastric catheters (86), or Carey-Alzate-Coons gastrojejunostomy catheters (36). Gastrojejunostomy tubes were placed in patients with gastroesophageal reflux or aspiration, gastric atony, or partial gastric obstruction. Ninety percent of the tubes were placed for feeding purposes. The technical success rate was 100%. Thirty-day follow-up was obtained in 89%. Thirty-day mortality was 26%, reflecting the substantial number of debilitated patients. No deaths were directly related to tube placement. Major morbidity was 6% and included hemorrhage, peritonitis, tube migration, and sepsis. Minor morbidity was 12%. There was no difference in 30-day mortality or feeding tolerance between the tube types (p less than .05). Patients with Foley catheters had more complications necessitating surgical intervention and an increased incidence of tube changes required within 30 days. These were the only statistically significant differences between the tubes (p less than .05). Our results show that percutaneous gastrostomy is a safe and effective means of gastroenteric feeding or decompression. Because of the fewer complications and ease of insertion, the Cope type of gastrostomy tube has become our preferred catheter for percutaneous feeding or decompression.
我们回顾了连续158例患者在两年内接受经皮胃造口术或经皮胃肠造口术的经验。使用的导管包括Foley导管(36例)、Cope型胃导管(86例)或Carey-Alzate-Coons胃空肠造口导管(36例)。胃空肠造口管用于患有胃食管反流或误吸、胃无力或部分胃梗阻的患者。90%的导管用于喂养目的。技术成功率为100%。89%的患者获得了30天的随访。30天死亡率为26%,这反映了虚弱患者的数量较多。没有死亡与导管置入直接相关。主要并发症发生率为6%,包括出血、腹膜炎、导管移位和败血症。轻微并发症发生率为12%。导管类型之间的30天死亡率或喂养耐受性没有差异(p<0.05)。使用Foley导管的患者有更多需要手术干预的并发症,并且在30天内需要更换导管的发生率增加。这些是导管之间唯一具有统计学意义的差异(p<0.05)。我们的结果表明,经皮胃造口术是一种安全有效的胃肠喂养或减压方法。由于并发症较少且插入容易,Cope型胃造口管已成为我们经皮喂养或减压的首选导管。